Toxicological Research

Toxicological Research is the journal of the Korean Society of Toxicology, published by Springer, and it takes in the effects of chemicals, drugs and environmental agents upon human and animal health.《毒理学研究》是韩国毒理学会的期刊，由 Springer 出版，关注化学品、药物与环境因素对人及动物健康的影响。

The journal gives priority to work that throws light on the mechanisms of toxic action rather than to a bare description of an effect.该刊优先刊登阐明毒性作用机制的工作，而非仅止于对效应的描述。

In the 2025 edition of the journal citation report it holds an impact factor of 3.3 and stands in the second quartile of toxicology.在 2025 年版期刊引证报告中，该刊的影响因子为 3.3，在毒理学类目中列第二区。

Scope

• The journal is comprehensive in its reach, and it welcomes contributions from a wide range of scientific disciplines that bear on toxicology.该刊的覆盖范围较为全面，欢迎来自与毒理学相关的广泛学科领域的来稿。

• An understanding of toxicological mechanism is set as the first priority, and a paper is expected to explain how an effect comes about.对毒理学机制的理解被列为首要，论文须说明某一效应是如何产生的。

• Chemicals form a large part of the subject, and studies of industrial substances, of pesticides and of food contaminants are admitted.化学品构成选题的一大部分，关于工业物质、农药与食品污染物的研究也在接纳之列。

• Drugs are treated alongside other agents, and work on the safety of a pharmaceutical compound before and after it reaches the clinic is taken.药物与其他因素并列处理，关于药物在进入临床前后安全性的工作受到收载。

• Environmental agents are covered, and the journal carries studies of air, water and soil pollutants and of the exposure routes that bring them to people.环境因素得到覆盖，该刊刊载空气、水与土壤污染物，以及把污染物带给人体的暴露途径方面的研究。

• Safety assessment is a standing subject, and the journal publishes work that feeds into the evaluation of a substance for regulatory purposes.安全性评估是常设题目，该刊发表可为物质监管评价提供依据的工作。

• Risk assessment is treated at the level of method, and papers on exposure estimation and on hazard characterisation are taken.风险评估在方法层面得到处理，关于暴露估计与危害表征的论文也在收载之列。

• Both laboratory and animal studies are admitted, and work that uses cell systems to screen for toxicity appears regularly.实验室研究与动物研究都在接纳之列，运用细胞体系筛查毒性的工作定期出现。

• Genetic toxicology is covered, and assays for mutation and for damage to the chromosomes are within the remit.遗传毒理学得到覆盖，检测突变与染色体损伤的试验属于收稿范围。

• Carcinogenicity and the mechanisms by which a substance promotes a tumour are admitted as subjects of their own.致癌性以及物质促进肿瘤形成的机制自成一个选题，受到收载。

• Organ directed toxicity is treated, and the journal carries work on the liver, the kidney, the lung and the nervous system.器官定向毒性得到处理，该刊刊载肝脏、肾脏、肺与神经系统方面的研究。

• Developmental and reproductive toxicity are admitted, and studies of exposure during pregnancy and its later consequences are taken.发育与生殖毒性也在接纳之列，关于孕期暴露及其远期后果的研究受到收载。

• Molecular toxicology has a place, and work on gene expression, on signalling and on the cell response to a toxicant is admitted.分子毒理学占有一席之地，关于基因表达、信号传导与细胞对毒物应答的工作受到收载。

• Biomarkers of exposure and of effect are covered, and the journal carries studies that link a measurable indicator to a harmful process.暴露与效应生物标志物得到覆盖，该刊刊载把可测指标与有害过程联系起来的研究。

• A global view of public health runs through the scope, and the editors look for work that may inform policy beyond a single country.公共卫生的全局视角贯穿选题范围，编辑方寻找可能超越单一国家而影响政策的工作。

History

• The journal is the property of the Korean Society of Toxicology, and its contents trace back to 1985.该刊归韩国毒理学会所有，其内容可上溯到 1985 年。

• The present title and its own pair of numbers date from the late years of the first decade of this century, when the journal was registered under its current name.现行刊名及其独立的一对刊号始于本世纪头一个十年的末期，当时刊物以现名登记。

• From 2020 the journal has been published by Springer, working from Singapore, and earlier volumes were issued by the society itself.自 2020 年起该刊由 Springer 在新加坡出版，此前的各卷由学会自行发行。

• The archive from 1985 to 2019 is kept by the society, and readers may reach those volumes through the society's own pages.1985 至 2019 年的存档由学会保存，读者可通过学会自身的页面查阅那些卷期。

• The journal comes out six times a year, and the sixth issue of volume 42 fell in November 2026.该刊每年出版六期，第 42 卷的第 6 期落在 2026 年 11 月。

• The print number is 1976-8257 and the electronic number is 2234-2753.印刷版编号为 1976-8257，电子版编号为 2234-2753。

• PubMed has carried the title from its twenty-sixth volume, and the full text is also deposited in PubMed Central.PubMed 自该刊第 26 卷起收录它，全文也存入 PubMed Central。

• The impact indicator has moved from 3.019 and 1.6 to 2.3, and it stood at 3.3 in the 2025 edition.影响因子从 3.019 与 1.6 变为 2.3，在 2025 年版为 3.3。

• The journal runs a hybrid open access model, and a share of its papers is free to read as soon as it is published.该刊实行混合开放获取模式，一部分论文在出版时即可免费阅读。

• A manuscript handling fee has been introduced, and the amount and the conditions are set out in the journal's instructions for authors.该刊引入了稿件处理费，金额与条件写在其作者须知之中。

• An EndNote style file is provided for authors, so that references can be prepared in the form the journal expects.刊物为作者提供 EndNote 样式文件，以便按刊物要求整理参考文献。

• The journal moved onto the publisher's platform in 2020, and the change brought the title into a wider medical and life sciences list.该刊于 2020 年迁入出版方的平台，这一变动把它带入更广阔的医学与生命科学刊群。

• Papers on the toxicity of nanoparticles and of other new materials appear, and the journal follows the questions these raise for safety.纳米颗粒及其他新材料的毒性论文有所出现，该刊追踪它们带来的安全性问题。

• Ecotoxicity is treated alongside human toxicology, and the journal carries work on the fate of a substance in soil, water and sediment.生态毒性与人类毒理学并列处理，该刊刊载物质在土壤、水与沉积物中归趋的工作。

• The journal reports on alternative methods, and it takes studies that seek to reduce the use of animals in a safety test.该刊报道替代方法，并收载力求减少安全性试验中动物使用的研究。

• Case reports of human exposure are admitted, and the journal carries accounts that tie a measured level in a person to an outcome.人类暴露的病例报告也在接纳之列，该刊刊载把人体内测得水平与结局联系起来的记述。

• The journal is read by toxicologists in universities, in industry and in regulatory agencies, and its reach is meant to be international.该刊的读者包括高校、产业界与监管机构中的毒理学家，其覆盖面意在国际。

Editors

• The editor-in-chief is Mi-Kyoung Kwak, who leads the editorial team.主编是（Mi-Kyoung Kwak），由她带领编辑团队。

• The journal is the official organ of the Korean Society of Toxicology, and the society is listed among its partners.该刊是韩国毒理学会的正式会刊，学会被列为其合作方之一。

• An editorial board covers the branches of the subject, from molecular toxicology to safety assessment.一支编委会覆盖该学科的各个分支，自分子毒理学延伸到安全性评估。

• Manuscripts are submitted through the publisher's online system and are sent to independent referees for peer review.稿件通过出版方的在线系统投递，并送交独立审稿人进行同行评审。

• The median time from submission to a first decision is given as fifteen days, and the journal publishes the figure with its metrics.从投稿到首次决定的中位时长记为十五天，该刊把这一数字连同指标一并公布。

• The journal states its expectations on ethics and on competing interests in a published policy, and authors are asked to comply.该刊在公开的政策中写明对伦理与利益冲突的要求，并要求作者遵守。

• Open access is offered beside the subscription route, so that authors may choose to make a paper free to read at once.该刊在订阅路径之外提供开放获取，作者可选择让自己的论文即时免费阅读。

• The board draws on universities, institutes and regulatory bodies in Korea and beyond, which suits a journal with a global public health aim.编委会取自韩国及境外的高校、研究所与监管机构，这与刊物面向全球公共卫生的宗旨相称。

• Authors are expected to report their methods in enough detail for the work to be repeated, and the journal asks for a clear statement of the advance claimed.作者须把方法写得足以让他人重现，该刊还要求清楚说明所主张的推进之处。

• The editorial office handles the review process and answers queries by email, and the journal publishes a pre-submission checklist for authors.编辑部负责评审流程并以电子邮件答复查询，该刊还向作者提供投稿前检查清单。